Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 219

1.

Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer.

Yanaihara T, Yokoba M, Onoda S, Yamamoto M, Ryuge S, Hagiri S, Katagiri M, Wada M, Mitsufuji H, Kubota M, Arai S, Kobayashi H, Yanase N, Abe T, Masuda N.

Cancer Chemother Pharmacol. 2007 Mar;59(4):419-27. Epub 2006 Jul 11.

PMID:
16832665
[PubMed - indexed for MEDLINE]
2.

Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.

Masuda N, Fukuoka M, Kudoh S, Matsui K, Kusunoki Y, Takada M, Nakagawa K, Hirashima T, Tsukada H, Yana T, et al.

J Clin Oncol. 1994 Sep;12(9):1833-41.

PMID:
7521905
[PubMed - indexed for MEDLINE]
3.

Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.

Shinkai T, Arioka H, Kunikane H, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Oshita F, Nishio M, Karato A, et al.

Cancer Res. 1994 May 15;54(10):2636-42.

PMID:
8168091
[PubMed - indexed for MEDLINE]
Free Article
4.

Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.

Masuda N, Fukuoka M, Kudoh S, Kusunoki Y, Matsui K, Nakagawa K, Hirashima T, Tamanoi M, Nitta T, Yana T, et al.

J Clin Oncol. 1994 Jan;12(1):90-6.

PMID:
7505810
[PubMed - indexed for MEDLINE]
5.

A phase I study of irinotecan in combination with amrubicin for advanced lung cancer patients.

Kaneda H, Kurata T, Tamura K, Uejima H, Nakagawa K, Fukuoka M.

Anticancer Res. 2006 May-Jun;26(3B):2479-85.

PMID:
16821636
[PubMed - indexed for MEDLINE]
Free Article
6.

Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.

Asakuma M, Yamamoto M, Wada M, Ryuge S, Katono K, Yokoba M, Fukui T, Takakura A, Otani S, Maki S, Igawa S, Yanaihara T, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Masuda N.

Cancer Chemother Pharmacol. 2012 Jun;69(6):1529-36. doi: 10.1007/s00280-012-1858-2. Epub 2012 Mar 14.

PMID:
22415148
[PubMed - indexed for MEDLINE]
7.

Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer.

Oshita F, Yamada K, Kato Y, Ikehara M, Noda K, Tanaka G, Nomura I, Suzuki R, Saito H.

Cancer Chemother Pharmacol. 2003 Jul;52(1):73-8. Epub 2003 May 16.

PMID:
12750839
[PubMed - indexed for MEDLINE]
8.

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.

Masuda N, Fukuoka M, Takada M, Kusunoki Y, Negoro S, Matsui K, Kudoh S, Takifuji N, Nakagawa K, Kishimoto S.

J Clin Oncol. 1992 Nov;10(11):1775-80.

PMID:
1328551
[PubMed - indexed for MEDLINE]
10.

Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.

Hotta K, Takigawa N, Kiura K, Tabata M, Umemura S, Ogino A, Uchida A, Bessho A, Segawa Y, Shinkai T, Nogami N, Harita S, Okimoto N, Ueoka H, Tanimoto M.

Anticancer Res. 2005 May-Jun;25(3c):2429-34.

PMID:
16080470
[PubMed - indexed for MEDLINE]
Free Article
11.

A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancer.

Hotta K, Ueoka H, Kiura K, Tabata M, Kuyama S, Satoh K, Kozuki T, Hisamoto A, Hosokawa S, Fujiwara K, Tanimoto M.

Lung Cancer. 2004 Jul;45(1):77-84.

PMID:
15196737
[PubMed - indexed for MEDLINE]
12.

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.

Abigerges D, Chabot GG, Armand JP, Hérait P, Gouyette A, Gandia D.

J Clin Oncol. 1995 Jan;13(1):210-21.

PMID:
7799022
[PubMed - indexed for MEDLINE]
13.

Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer.

Sugiura T, Ariyoshi Y, Negoro S, Nakamura S, Ikegami H, Takada M, Yana T, Fukuoka M.

Invest New Drugs. 2005 Aug;23(4):331-7.

PMID:
16012792
[PubMed - indexed for MEDLINE]
14.

Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors.

Catimel G, Chabot GG, Guastalla JP, Dumortier A, Cote C, Engel C, Gouyette A, Mathieu-Boué A, Mahjoubi M, Clavel M.

Ann Oncol. 1995 Feb;6(2):133-40.

PMID:
7786821
[PubMed - indexed for MEDLINE]
15.

Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatin.

Kudoh S, Fukuoka M, Masuda N, Yoshikawa A, Kusunoki Y, Matsui K, Negoro S, Takifuji N, Nakagawa K, Hirashima T, et al.

Jpn J Cancer Res. 1995 Apr;86(4):406-13.

PMID:
7775263
[PubMed - indexed for MEDLINE]
16.

Phase I/II and pharmacologic study of irinotecan and carboplatin for patients with lung cancer.

Sato M, Ando M, Minami H, Ando Y, Ando M, Yamamoto M, Sakai S, Watanabe A, Ikeda T, Sekido Y, Saka H, Shimokata K, Hasegawa Y.

Cancer Chemother Pharmacol. 2001 Dec;48(6):481-7.

PMID:
11800029
[PubMed - indexed for MEDLINE]
17.

A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer.

Inoue A, Yamazaki K, Maemondo M, Suzuki T, Kimura Y, Kanbe M, Isobe H, Nishimura M, Saijo Y, Nukiwa T.

J Thorac Oncol. 2006 Jul;1(6):551-5.

PMID:
17409916
[PubMed - indexed for MEDLINE]
18.

Phase I and pharmacologic study of docetaxel and irinotecan in advanced non-small-cell lung cancer.

Masuda N, Negoro S, Kudoh S, Sugiura T, Nakagawa K, Saka H, Takada M, Niitani H, Fukuoka M.

J Clin Oncol. 2000 Aug;18(16):2996-3003.

PMID:
10944133
[PubMed - indexed for MEDLINE]
19.

Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancer.

Kasai T, Oka M, Soda H, Tsurutani J, Fukuda M, Nakamura Y, Kawabata S, Nakatomi K, Nagashima S, Takatani H, Fukuda M, Kinoshita A, Kohno S.

Eur J Cancer. 2002 Sep;38(14):1871-8.

PMID:
12204669
[PubMed - indexed for MEDLINE]
20.

A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.

Fukuda M, Nakamura Y, Kasai T, Nagashima S, Nakatomi K, Doi S, Nakano H, Takatani H, Fukuda M, Kinoshita A, Soda H, Tsukamoto K, Oka M, Kohno S; Nagasaki Thoracic Oncology Group.

J Thorac Oncol. 2009 Jun;4(6):741-5. doi: 10.1097/JTO.0b013e3181a52946.

PMID:
19404211
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk